The blend is not approved for human use Tesamorelin alone is FDA-approved as EGRIFTA for HIV-associated lipodystrophy, while Ipamorelin is not FDA-approved for any indication
reasonable expectations and regular use produce long-lasting effects
A., Day, A
Tested for irritation and manufactured with care in South Korea
This is only prescribed if the patient meets certain indications: - Patient is at least 18 years of age - Patient is receiving calcium and Vitamin D supplementation if dietary intake is inadequate - Patient must not have hypocalcemia - Patient has not had a myocardial infarction or stroke within the preceding year - The injection will not be used in combination with bisphosphonates, denosumab, or parathyroid hormone analogs/related peptides - Patient must be at a high risk for fracture, or have multiple risk factors for fracture - Patient has a documented diagnosis of osteoporosis ## **Documentation requirements for J3111** As with any HCPCS code, it's important to have sufficient documentation that satisfies your insurer's coding guidelines, requirements, related policy articles, and local coverage determinations
Outcomes included restored walking indices, reversal of contracture, preservation of muscle mass, and complete structural reattachment confirmed by imaging